SLC6A3 and attention deficit-hyperactivity disorder: However, Volkow’s [118] group found that 12 months of methylphenidate treatment significantly increased striatal DA transporter availability in ADHD (caudate, putamen, and ventral striatum) by 24 %, whereas there were no changes in control subjects retested at the 12-month interval.